Gene · 8291
Papers2,035
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,035
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A survey on mutation spectrum in Iranian patients with limb-girdle muscular dystrophies. | Hum Genomics | 2025 | 40361203 | PubTator, text mining | PubMed |
| Multiple sclerosis severity variant in DYSF-ZNF638 locus associates with neuronal loss and inflammation. | iScience | 2025 | 40352730 | PubTator, text mining | PubMed |
| Decoding the role of microtubules: a trafficking road for vesicle. | Theranostics | 2025 | 40303338 | PubTator, text mining | PubMed |
| Machine Learning Identification of Neutrophil Extracellular Trap-Related Genes as Potential Biomarkers and Therapeutic Targets for Bronchopulmonary Dysplasia. | Int J Mol Sci | 2025 | 40244055 | PubTator, text mining | PubMed |
| Treatabolome for finely targeting muscle pathology in LGMD. | Acta Myol | 2025 | 40183440 | PubTator, text mining | PubMed |
| The Association Between Statin Drugs and Rhabdomyolysis: An Analysis of FDA Adverse Event Reporting System (FAERS) Data and Transcriptomic Profiles. | Genes (Basel) | 2025 | 40149400 | PubTator, text mining | PubMed |
| Identification of glucocorticoid-related genes in systemic lupus erythematosus using bioinformatics analysis and machine learning. | PLoS One | 2025 | 40131879 | PubTator, text mining | PubMed |
| High-throughput screening identifies bazedoxifene as a potential therapeutic for dysferlin-deficient limb girdle muscular dystrophy. | Br J Pharmacol | 2025 | 40108832 | PubTator, text mining | PubMed |
| Muscle MRI Pattern in Dysferlinopathy and its Correlation with Dysferlin Gait. | Ann Indian Acad Neurol | 2025 | 40079678 | PubTator, text mining | PubMed |
| Limb-Girdle Muscular Dystrophy Type 2 Caused by a Novel Homozygous Mutation in DYSF in a Consanguineous Family. | Int J Rheum Dis | 2025 | 40062450 | PubTator, text mining | PubMed |
| Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin function in dysferlinopathy patient-derived muscle cells. | Mol Ther Nucleic Acids | 2025 | 39991471 | PubTator, text mining | PubMed |
| Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin function in dysferlinopathy patient-derived muscle cells. | Mol Ther Nucleic Acids | 2025 | 39967852 | PubTator, text mining | PubMed |
| [Ultrastructural changes of skeletal muscle tissue of patients with dysferlinopathy]. | Arkh Patol | 2025 | 39943726 | PubTator, text mining | PubMed |
| Analysis of Exon Skipping Applicability for Dysferlinopathies. | Cells | 2025 | 39936969 | PubTator, text mining | PubMed |
| Whole genome sequencing identifies novel candidate genetic variants in canine stomatocytosis. | Gene | 2025 | 39929273 | PubTator, text mining | PubMed |
| Limb-Girdle Muscular Dystrophies (LGMD): Clinical features, diagnosis and genetic variability through next generation sequencing. | Glob Med Genet | 2025 | 39925440 | PubTator, text mining | PubMed |
| Rapid Quantitative Assessment of Muscle Sodium Dynamics After Exercise Using 23Na-MRI in Dysferlinopathy and Healthy Controls. | J Cachexia Sarcopenia Muscle | 2025 | 39900102 | PubTator, text mining | PubMed |
| Bioinformatics approach reveals the critical role of inflammation-related genes in age-related hearing loss. | Sci Rep | 2025 | 39837906 | PubTator, text mining | PubMed |
| Chronic pain as a presenting feature of dysferlinopathy. | Neuromuscul Disord | 2025 | 39798170 | PubTator, text mining | PubMed |
| Clinical features, mutation spectrum and factors related to reaching molecular diagnosis in a cohort of patients with distal myopathies. | J Neurol | 2025 | 39775307 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8291/papers?page=5